Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology
TDP-43 pathology is a hallmark of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal lobar degeneration (FTLD). Namely, both diseases feature aggregated and phosphorylated TDP-43 containing inclusions in the cytoplasm and a loss of nuclear TDP-43 in affected neurons. It has been reported that ta...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/10127822ae8a4b869c780c0f430e8e11 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:10127822ae8a4b869c780c0f430e8e11 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:10127822ae8a4b869c780c0f430e8e112021-12-04T04:33:12ZTau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology1095-953X10.1016/j.nbd.2021.105548https://doaj.org/article/10127822ae8a4b869c780c0f430e8e112021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0969996121002977https://doaj.org/toc/1095-953XTDP-43 pathology is a hallmark of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal lobar degeneration (FTLD). Namely, both diseases feature aggregated and phosphorylated TDP-43 containing inclusions in the cytoplasm and a loss of nuclear TDP-43 in affected neurons. It has been reported that tau tubulin kinase (TTBK)1/2 phosphorylate TDP-43 and TTBK1/2 overexpression induced neuronal loss and behavioral deficits in a C. elegans model of ALS. Here we aimed to elucidate the molecular mechanisms of TTBK1 in TDP-43 pathology. TTBK1 levels were observed to be elevated in ALS patients' post-mortem motor cortex. Also, TTBK1 was found to phosphorylate TDP-43 at disease-relevant sites in vitro directly, and this phosphorylation accelerated TDP-43 formation of high molecular species. Overexpression of TTBK1 in mammalian cells induced TDP-43 phosphorylation and the construction of high molecular species, concurrent with TDP-43 mis-localization and cytoplasmic inclusions. In addition, when TTBK1 was knocked down or pharmacologically inhibited, TDP-43 phosphorylation and aggregation were significantly alleviated. Functionally, TTBK1 knockdown could rescue TDP-43 overexpression-induced neurite and neuronal loss in iPSC-derived GABAergic neurons. These findings suggest that phosphorylation plays a critical role in the pathogenesis of TDP-43 pathology and that TTBK1 inhibition may have therapeutic potential for the treatment of ALS and FTLD.Yuan TianYi WangAngela M. JablonskiYinghui HuJonathan A. SugamMarkus KoglinShawn J. StachelHeather ZhouJason M. UslanerSophie Parmentier-BatteurElsevierarticleTTBK1ALSFTLDTDP-43PathologyPhosphorylationNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENNeurobiology of Disease, Vol 161, Iss , Pp 105548- (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
TTBK1 ALS FTLD TDP-43 Pathology Phosphorylation Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 |
spellingShingle |
TTBK1 ALS FTLD TDP-43 Pathology Phosphorylation Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Yuan Tian Yi Wang Angela M. Jablonski Yinghui Hu Jonathan A. Sugam Markus Koglin Shawn J. Stachel Heather Zhou Jason M. Uslaner Sophie Parmentier-Batteur Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology |
description |
TDP-43 pathology is a hallmark of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal lobar degeneration (FTLD). Namely, both diseases feature aggregated and phosphorylated TDP-43 containing inclusions in the cytoplasm and a loss of nuclear TDP-43 in affected neurons. It has been reported that tau tubulin kinase (TTBK)1/2 phosphorylate TDP-43 and TTBK1/2 overexpression induced neuronal loss and behavioral deficits in a C. elegans model of ALS. Here we aimed to elucidate the molecular mechanisms of TTBK1 in TDP-43 pathology. TTBK1 levels were observed to be elevated in ALS patients' post-mortem motor cortex. Also, TTBK1 was found to phosphorylate TDP-43 at disease-relevant sites in vitro directly, and this phosphorylation accelerated TDP-43 formation of high molecular species. Overexpression of TTBK1 in mammalian cells induced TDP-43 phosphorylation and the construction of high molecular species, concurrent with TDP-43 mis-localization and cytoplasmic inclusions. In addition, when TTBK1 was knocked down or pharmacologically inhibited, TDP-43 phosphorylation and aggregation were significantly alleviated. Functionally, TTBK1 knockdown could rescue TDP-43 overexpression-induced neurite and neuronal loss in iPSC-derived GABAergic neurons. These findings suggest that phosphorylation plays a critical role in the pathogenesis of TDP-43 pathology and that TTBK1 inhibition may have therapeutic potential for the treatment of ALS and FTLD. |
format |
article |
author |
Yuan Tian Yi Wang Angela M. Jablonski Yinghui Hu Jonathan A. Sugam Markus Koglin Shawn J. Stachel Heather Zhou Jason M. Uslaner Sophie Parmentier-Batteur |
author_facet |
Yuan Tian Yi Wang Angela M. Jablonski Yinghui Hu Jonathan A. Sugam Markus Koglin Shawn J. Stachel Heather Zhou Jason M. Uslaner Sophie Parmentier-Batteur |
author_sort |
Yuan Tian |
title |
Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology |
title_short |
Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology |
title_full |
Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology |
title_fullStr |
Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology |
title_full_unstemmed |
Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology |
title_sort |
tau-tubulin kinase 1 phosphorylates tdp-43 at disease-relevant sites and exacerbates tdp-43 pathology |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/10127822ae8a4b869c780c0f430e8e11 |
work_keys_str_mv |
AT yuantian tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology AT yiwang tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology AT angelamjablonski tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology AT yinghuihu tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology AT jonathanasugam tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology AT markuskoglin tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology AT shawnjstachel tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology AT heatherzhou tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology AT jasonmuslaner tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology AT sophieparmentierbatteur tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology |
_version_ |
1718372952674664448 |